Cargando…
A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) outbreak initiated the global coronavirus disease 2019 (COVID‐19) pandemic resulting in 42.9 million confirmed infections and > 1.1 million deaths worldwide as of October 26, 2020. Remdesivir is a broad‐spectrum nucleotide prodrug s...
Autores principales: | Hanafin, Patrick O., Jermain, Brian, Hickey, Anthony J., Kabanov, Alexander V., Kashuba, Angela DM., Sheahan, Timothy P., Rao, Gauri G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894405/ https://www.ncbi.nlm.nih.gov/pubmed/33296558 http://dx.doi.org/10.1002/psp4.12584 |
Ejemplares similares
-
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
por: Jermain, Brian, et al.
Publicado: (2020) -
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
por: Yan, Daisy, et al.
Publicado: (2021) -
Interspecies extrapolation by physiologically based pharmacokinetic modeling
por: Ghallab, Ahmed
Publicado: (2015) -
Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection
por: Amantana, Adams, et al.
Publicado: (2013) -
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
por: Deb, Subrata, et al.
Publicado: (2021)